АЛЛЕРГИЯ НА АНТИБИОТИКИ У ДЕТЕЙ: КТО ВИНОВАТ И ЧТО ДЕЛАТЬ?
https://doi.org/10.15690/pf.v10i6.895
Аннотация
Аллергические реакции на антибиотики в педиатрической практике являются серьезной проблемой и сложной задачей для педиатров: это обусловлено трудностями в диагностике, интерпретации анамнестических данных и последующим выбором адекватной антибактериальной терапии. В обзоре описаны основные типы аллергических реакций на антибактериальные препараты, чаще других используемых у детей. Отдельный акцент сделан на факторах риска развития лекарственной гиперчувствительности, описаны клинические проявления аллергии на антибиотики и особенности аллергических реакций на отдельные препараты. Рассматриваются клинические подходы и алгоритмы
Об авторах
И. В. Андреева
НИИ антимикробной химиотерапии ГБОУ ВПО «Смоленская государственная медицинская академия» Минздрава России
Россия
кандидат медицинских наук, доцент, старший научный сотрудник НИИ антимикробной химиотерапии ГБОУ ВПО «Смоленская государственная медицинская академия» Министерства здравоохранения России
Россия
кандидат медицинских наук, доцент, старший научный сотрудник НИИ антимикробной химиотерапии ГБОУ ВПО «Смоленская государственная медицинская академия» Министерства здравоохранения России
О. У. Стецюк
НИИ антимикробной химиотерапии ГБОУ ВПО «Смоленская государственная медицинская академия» Минздрава России
Россия
Россия
Список литературы
1. Ibia E. O., Schwartz R. H., Wiedermann B. L. Antibiotic rashes in children: a survey in a private practice setting. Arch. Dermatol. 2000; 136 (7): 849–854.
2. Menniti-Ippolito G., Raschetti R., Da Cas R. et al. Active monitoring of adverse drug reactions in children. Italian Paediatric Pharmaco surveillance Multicenter Group. Lancet. 2000; 355: 1613–1614.
3. Bourgeois F. T., Mandl K. D., Valim C. et al. Pediatric adverse drug events in the outpatient setting: an 11-year national analysis. Pediatrics. 2009; 124 (4): 744–750.
4. Bigby M., Jick S., Jick H. et al. Drug-induced cutaneous reactions: a report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA. 1986; 256: 3358–3363.
5. Joint Task Force on Practice Parameters. Disease Management of Drug Hypersensitivity: A Practice Parameter. Ann. Allergy Asthma Immunol. 1999; 83.
6. Langley J., Halperin S. Allergy to antibiotics in children: Perception versus reality. Paediatr. Child Health. 2002; 7 (4): 233–237.
7. Kraemer M., Caprye-Boos H., Berman H. Increased use of medical services and antibiotics by children who claim a prior penicillin sensitivity. West J. Med. 1987; 146: 697–700.
8. Pirmohamed M., James S., Meakin S. et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004; 329: 15–19.
9. Solensky R., Earl H. S., Gruchalla R. S. Clinical approach to penicillin allergic patients: A survey. Ann. Allergy Asthma Immunol. 2000; 84: 329–333.
10. Riedl M. A., Casillas A. M. Adverse drug reactions: types and treatment options. Am. Fam. Physician. 2003; 68 (9): 1781–1790.
11. Karch F. E., Lasagna L. Adverse drug reactions. A critical review. JAMA. 1975; 234: 1236–1241.
12. Johansson S. G., Bieber T., Dahl R. et al. Revised nomenclature for allergy for global use: report of the nomenclature review committee of the World Allergy Organization, October 2003. J. Allergy Clin. Immunol. 2004; 113: 832–6.
13. Janeway C., Travers C., Walport M. et al. Immunology: The Immune System in Health and Disease. 5th ed. New York: Garland. 2001.
14. Sanz E., Boada J. Adverse drug reactions in paediatric outpatients. Int. J. Clin. Pharmacol Res. 1987; 7: 169–172.
15. Woods C. G., Rylance M. E., Cullen R. E. et al. Adverse reactions to drugs in children. BMJ. 1987; 294: 869–870.
16. Cohen A. L., Budnitz D. S., Weidenbach K. N. et al. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents. J. Pediatr. 2008; 152 (3): 416–421.
17. Prober C. Cepahalosporins: An update. Pediatr. Rev. 1998; 19: 118–27.
18. Borish L. Immune mechanisms of drug allergy. Immunol Allergy Clin. North Am. 1998; 18: 717–729.
19. Langley J., Halperin S., Bortolussi R. History of penicillin allergy and referral for skin testing: Evaluation of a pediatric program. 39th Annual Meeting of the Infectious Diseases Society of America. San Francisco, California. October 25–28, 2001.
20. Pichichero M. E., Pichichero D. M. Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: Reliability of examination assessed by skin testing and oral challenge. J. Pediatr. 1998; 132: 137–143.
21. Mendelson L. M., Ressler C., Rosen J. P. et al. Routine elective penicillin allergy skin testing in children and adolescents: Study of sensitization. J. Allergy Clin. Immunol. 1984; 73: 76–81.
22. Huang S. W., Borum P. R. Study of skin rashes after antibiotic use in young children. Clin. Pediatr. (Phila). 1998; 37: 601–607.
23. Granowitz E. V., Brown R. B. Antibiotic adverse reactions and drug interactions. Crit Care Clin. 2008; 24: 421–442.
24. Kerr J. R. Penicillin allergy: a study of incidence as reported by patients. Br. J. Clin. Pract. 1994; 48: 5–7.
25. Ahlstedt S. Penicillin allergy: can the incidence be reduced? Allergy. 1984; 39: 151–164.
26. International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet. 1991; 337 (8753): 1308–1310.
27. Lee C. E., Zembower T. R., Fotis M. A. et al. The incidence of antimicrobial allergies in hospitalized patients: implications regarding prescribing patterns and emerging bacterial resistance. Arch. Intern. Med. 2000; 160 (18): 2819–22.
28. Ponvert C., Perrin Y., Bados-Albiero A. et al. Allergy to betalactam antibiotics in children: results of a 20-year study based on clinical history, skin and challenge tests. Pediatr. Allergy Immunol. 2011; 22 (4): 411–8.
29. Shehab N., Patel P. R., Srinivasan A. et al. Emergency department visits for antibiotic-associated adverse events. Clin. Infect. Dis. 2008; 47: 735–743.
30. Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma and Immunology; American College of Allergy, Asthma and Immunology; Joint Council of Allergy, Asthma and Immunology. Drug allergy: an updated practice parameter. Ann. Allergy Asthma Immunol. 2010; 105 (4): 259–273.
31. Haddi E., Charpin D., Tafforeau M. et al. Atopy and systemic reactions to drugs. Allergy. 1990; 45 (3): 236–239.
32. Choi I. S., Han E. R., Lim S. W. Beta-lactam antibiotic sensitization and its relationship to allergic diseases in tertiary hospital nurses. Allergy Asthma Immunol. Res. 2010; 2 (2): 114–122.
33. Patterson R., Grammer L. C., Greenberger P. A. Allergic Diseases: Diagnosis and Management. Lippincott Williams & Wilkins; 5th edition, 1997. 634 p.
34. Babe K. S., Serafin W. E. Histamine bradykinin, and their antagonists. In: Hardman J. G., Limbird L. E., Molinoff P. В., Ruddon R. W., eds. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill. 1996. Р. 581–600.
35. Macy E., Poon K.-Y. T. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am. J. Med. 2009; 122 (8): 778 (e1–7).
36. Rosario N. A., Grumach A. S. Allergy to beta-lactams in pediatrics: a practical approach. J. Pediatr. (Rio J). 2006; 82 (5 Suppl.): S181–188.
37. Gruchalla R. S., Pirmohamed M. Clinical practice. Antibiotic allergy. N. Engl. J. Med. 2006; 354 (6): 601–609.
38. Shapiro S., Siskind V., Slone D. et al. Drug rash with ampicillin and other penicillins. Lancet. 1969; 2: 969–972.
39. Kearns D. L., Shira J. E., Go S. et al. Ampicillin rash in children. Am. J. Dis. Child. 1973; 125: 187–290.
40. Patel B. M. Skin rash with infectious mononucleosis and ampicillin. Pediatrics. 1967; 40: 910–911.
41. Romano A., Di Fonso M., Papa G. et al. Evaluation of adverse cutaneous reactins to aminopenicillins with emphasis on those manifested by maculopapular rashes. Allergy. 1995; 50: 113–118.
42. Chovel-Sella A., Ben Tov A., Lahav E. et al. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. Pediatrics. 2013; 131 (5): e1424–147.
43. Stember R. H. Prevalence of skin test reactivity in patients with convincing, vague, and unacceptable histories of penicillin allergy. Allergy Asthma Proc. 2005; 26 (1): 59–64.
44. Solensky R., Earl H. S., Gruchalla R. S. Penicillin allergy: prevalence of vague history in skin test-positive patients. Ann. Allergy Asthma Immunol. 2000; 85 (3): 195–199.
45. Pirmohamed M., Kitteringham N. R., Park B. K. The role of active metabolites in drug toxicity. Drug. Saf. 1994; 11: 114–144.
46. Spanou Z., Keller M., Britschgi M. et al. Involvement of drugspecific T cells in acute drug-induced interstitial nephritis. J. Am. Soc. Nephrol. 2006; 17 (10): 2919–2927.
47. Biuk D., Jukic T., Vukojevic N. et al. Serum sickness and uveitis. Coll Antropol. 2005; 29 (Suppl. 1): 127–18.
48. Schnyder B. Approach to the patient with drug allergy. Med Clin North Am. 2010; 94 (4): 665–79.
49. Criado P. R., Criado R. F., Avancini J. de M. et al. Drug reaction with Eosinophilia and Systemic Symptoms (DRESS)/Drug–induced Hypersensitivity Syndrome (DIHS): a review of current concepts. An Bras Dermatol. 2012; 87 (3): 435–449.
50. Cacoub P., Musette P., Descamps V. et al. The DRESS syndrome: a literature review. Am. J. Med. 2011; 124 (7): 588–597.
51. Peyrie`re H., Dereure O., Breton H. et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br. J. Dermatol. 2006; 155 (2): 422–8.
52. Neuman M. G., McKinney K. K., Nanau R. M. et al. Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation. Transl. Res. 2013; 161 (5): 430–40.
53. Shiohara T., Inaoka M., Kano Y. Drug induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesvirus and antiviral and antidrug immune responses. Allergol Int. 2006; 55 (1): 1–8.
54. Roujeau J. C., Stern R. S. Severe adverse cutaneous reactions to drugs. N. Engl. J. Med. 1994; 331 (19): 1272–1285.
55. Bastuji-Garin S., Rzany B., Stern R. S. et al. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol. 1993; 129: 92–96.
56. French L. E. Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding. Allergol Int. 2006; 55: 9–16.
57. Borchers A. T., Lee J. L., Naguwa S. M. et al. Stevens-Johnson syndrome and toxic epidermal necrolysis. Autoimmun. Rev. 2008; 7: 598–605.
58. Thong B. Y. Update on the management of antibiotic allergy. Allergy Asthma Immunol. Res. 2010; 2 (2): 77–86.
59. Neu H. C., Wilson A. P. R., Gruneberg R. N. Amoxycillin/Clavulanic Acid: a Review of its Efficacy in over 38,500 Patients from 1979 to 1992. J. Chemother. 1993; 5: 67–93.
60. Thompson J. W., Jacobs R. F. Adverse effects of newer cephalosporins. An update. Drug. Saf. 1993; 9: 132–42.
61. Norrby S. R. Side Effects of Cephalosporins. Drugs. 1995; 34 (Suppl. 2): 105–120.
62. Naldi L., Conforti A., Venegoni M. et al. Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. Br. J. Clin. Pharmacol. 1999; 48: 839–846.
63. Mockenhaupt M., Schopf E. Progress in Allergy and Clinical Immunology, vol. 4, Cancun (Mexico): proceedings of the XVIth International Congress of Allergology and Clinical Immunology. Cancun, Mexico. 1997. P. 352–360.
64. Mahboob A., Haroon T. S. Drugs causing fixed eruptions: a study of 450 cases. Int. J. Dermatol. 1998; 37: 833–838.
65. van der Klauw M. M., Wilson J. H., Stricker B. H. Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974–1994) and review of the literature. Clin. Exp. Allergy. 1996; 26: 1355–1363.
66. Pedersen-Bjergaard U., Andersen M., Hansen P. B. Thrombocytopenia induced by noncytotoxic drugs in Denmark 1968–91. J. Intern. Med. 1996; 239: 509–515.
67. Henry D. C., Nenad R. C., Iravani A. et al. Comparison of sparfloxacin and ciprofloxacin in the treatment of communityacquired acute uncomplicated urinary tract infection in women. Sparfloxacin Multicenter Uncomplicated Urinary Tract Infection Study Group. Clin. Ther. 1999; 21: 966–981.
68. Araujo L., Demoly P. Macrolides allergy. Curr. Pharm. Des. 2008; 14 (27): 2840–2862.
69. Demoly P., Benahmed S., Valembois M. et al. Allergy to macrolide antibiotics. Review of the literature. Presse Med. 2000; 29 (6): 321–326.
70. Van Joost T., Dikland W., Stolz E., Prens E. Sensitization to chloramphenicol: a persistent problem. Contact Dermatitis. 1986; 14: 176–178.
71. Shalit I., Marks M. I. Chloramphenicol in the 1980s. Drugs. 1984; 28: 281–291.
72. Palchick B. A., Funk E. A., McEntire J. E., Hamory B. H. Anaphylaxis due to chloramphenicol. Am. J. Med. Sci. 1984; 288: 43–45.
73. Liphshitz I., Loewenstein A. Anaphylactic reaction following application of chloramphenicol eye ointment. Br. J. Ophthalmol. 1991; 75: 64.
74. Schewach-Millet M., Shpiro D. Urticaria and angioedema due to topically applied chloramphenicol ointment. Arch. Dermatol. 1985; 121: 587.
75. Perkins J. B., Raasch R. H. Hypersensitivity reaction following chloramphenicol administration in a patient with typhoid fever. Drug. Intell Clin. Pharm. 1987; 21: 343–345.
76. Gregoriou S., Rigopoulos D., Katsambas A. et al. Etiologic aspects and prognostic factors of patients with chronic urticaria: nonrandomized, prospective, descriptive study. J. Cutan Med. Surg. 2009; 13: 198–203.
77. Wedi B., Raap U., Kapp A. Chronic urticaria and infections. Curr. Opin. Allergy Clin. Immunol. 2004; 4: 387–396.
78. Marshall J. S. Mast-cell responses to pathogens. Nat Rev. Immunol. 2004; 4: 787–799.
79. Eigenmann P.A. , Atanaskovic-Markovic M., J. Hourihane O'B., Lack G., Lau S., Matricardi P. M., Muraro A., Namazova Baranova L., Nieto A., Papadopoulos N. G., Rethy L.A., Roberts G., Rudzeviciene O., Wahn U., Wickman M., Hоst A. Testing children for allergies: why, how, who and when. An updated statement of the European Academy of Allergy and Clinical Immunology (EAACI) Section on Pediatrics and the EAACI-Clemens von Pirquet Foundation. Pediatric Allergy and Immunology. 2013; 24 (2): 195–209.
80. Caubet J. C., Eigenmann P. A. Managing possible antibiotic allergy in children. Curr. Opin Infect. Dis. 2012; 25 (3): 279–285.
81. Kavadas F. D., Kasprzak A., Atkinson A. R. Antibiotic skin testing accompanied by provocative challenges in children is a useful clinical tool. Allergy Asthma Clin. Immunol. 2013; 9 (1): 22.
82. McLean-Tooke A., Aldridge C., Stroud C. et al. Practical management of antibiotic allergy in adults. J. Clin. Pathol. 2011; 64 (3): 192–199.
83. Romano A., Gaeta F., Valluzzi R. L. et al. Diagnosing hypersensitivity reactions to cephalosporins in children. Pediatrics. 2008; 122 (3): 521–527.
Рецензия
Для цитирования:
Андреева И.В., Стецюк О.У. АЛЛЕРГИЯ НА АНТИБИОТИКИ У ДЕТЕЙ: КТО ВИНОВАТ И ЧТО ДЕЛАТЬ? Педиатрическая фармакология. 2013;10(6):42-52. https://doi.org/10.15690/pf.v10i6.895
For citation:
Andreeva I.V., Stetsyuk O.U. ALLERGY TO ANTIBIOTICS IN CHILDREN: WHO IS TO BLAME AND WHAT TO DO? Pediatric pharmacology. 2013;10(6):42-52. https://doi.org/10.15690/pf.v10i6.895
Просмотров: 2419
Послать статью по эл. почте 